<SEC-DOCUMENT>0001193125-16-693960.txt : 20160826
<SEC-HEADER>0001193125-16-693960.hdr.sgml : 20160826
<ACCEPTANCE-DATETIME>20160826163602
ACCESSION NUMBER:		0001193125-16-693960
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20160826
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160826
DATE AS OF CHANGE:		20160826

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMARIN CORP PLC\UK
		CENTRAL INDEX KEY:			0000897448
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21392
		FILM NUMBER:		161855198

	BUSINESS ADDRESS:	
		STREET 1:		FIRST FLOOR, BLOCK 3, THE OVAL,
		STREET 2:		SHELBOURNE ROAD, BALLSBRIDGE
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			00000
		BUSINESS PHONE:		353 1 6699 020

	MAIL ADDRESS:	
		STREET 1:		FIRST FLOOR, BLOCK 3, THE OVAL,
		STREET 2:		SHELBOURNE ROAD, BALLSBRIDGE
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMARIN PHARMACEUTICALS PLC
		DATE OF NAME CHANGE:	20000201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ETHICAL HOLDINGS PLC
		DATE OF NAME CHANGE:	19930322
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d100031d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section&nbsp;13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of Earliest Event Reported): August&nbsp;26, 2016 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Amarin Corporation plc </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>England and Wales</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>0-21392</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Not applicable</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2 Pembroke House, Upper Pembroke Street 28-32,</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Dublin 2, Ireland</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Not applicable</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: +353 1 6699 020 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Not Applicable </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Former
name or former address, if changed since last report </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;3.02</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Unregistered Sales of Equity Securities. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&nbsp;26, 2016, Amarin Corporation
plc (the &#147;Company&#148;) gave notice to mandatorily exchange the $31.266 million in aggregate principal amount of its November 2015 3.50% Exchangeable Senior Notes due 2032 (the &#147;2015 Notes&#148;) into 384.6154 of the Company&#146;s
American Depositary Shares (the &#147;Shares&#148;) representing a corresponding number of the Company&#146;s ordinary shares, par value &pound;0.50&nbsp;per share (the &#147;Ordinary Shares&#148;), per $1,000.00 of principal amount of the 2015
Notes on September&nbsp;12, 2016, subject to certain adjustments as provided in the 2015 Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Separately, on August&nbsp;26, 2016,
Corsicanto Limited (&#147;Corsicanto&#148;), a wholly-owned subsidiary of the Company, gave notice to mandatorily exchange the $118.734 million of aggregate principal amount of its May 2014 3.50% Exchangeable Senior Notes due 2032 (the &#147;2014
Notes&#148; and together with the 2015 Notes, the &#147;Notes&#148;) into 384.6154 of the Company&#146;s Shares per $1,000.00 of principal amount of the 2014 Notes on September&nbsp;12, 2016, subject to certain adjustments as provided in the
Indenture, dated May 20, 2014 by and among Corsicanto, the Company, and Wilmington Trust, National Association, as trustee, governing the 2014 Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the aggregate principal amount of each series of Notes that will be exchanged into Shares pursuant to the
exchange of the Notes (the &#147;Transactions&#148;). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="83%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:58.40pt; font-size:8pt; font-family:Times New Roman"><B>Convertible Note</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November 2015 3.50% Exchangeable Senior Notes due 2032 of Amarin Corporation plc</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">31,266,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May 2014 3.50% Exchangeable Senior Notes due 2032 of Corsicanto Limited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">118,734,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>150,000,000.00</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;&nbsp;</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to compliance with certain conditions, the Company and Corsicanto have the right to mandatorily
exchange the 2015 Notes and the 2014 Notes, respectively, in whole or in part, if the daily volume-weighted average price per Share equals or exceeds $2.86 for at least twenty trading days in any thirty-trading day window. This condition was met for
the thirty-trading-day window ending, and including, August&nbsp;26, 2016. The Company will issue the Shares pursuant to the exchange of the Notes in reliance on the exemption from registration provided by Section&nbsp;3(a)(9) of the Securities Act
of 1933, as amended. The Transactions will retire all of the outstanding 2015 Notes and 2014 Notes, and the issuance of the Shares will also satisfy the Company&#146;s obligations with respect to any accrued and unpaid interest on the Notes as of
the date of the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&nbsp;26, 2016, the Company issued a press release announcing the Transactions. The full text of
the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top">Exhibits: </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:39.10pt; font-size:8pt; font-family:Times New Roman"><B>Exhibit&nbsp;No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release, dated August 26, 2016</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Date: August&nbsp;26, 2016</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Amarin Corporation plc</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John Thero</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">John Thero</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">President and Chief Executive Officer</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:25.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit<BR>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release, dated August 26, 2016</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d100031dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt; margin-left:15%; text-indent:6%" ALIGN="center">


<IMG SRC="g100031g0826093420644.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Amarin Announces Mandatory Exchange of Exchangeable Senior Notes </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Issued in May 2014 and November 2015 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BEDMINSTER, N.J. and DUBLIN, Ireland, August 26, 2016 &#151; Amarin Corporation plc (NASDAQ: AMRN) (&#147;Amarin&#148;), announced today that its wholly owned
subsidiary, Corsicanto Limited, a private limited company incorporated under the laws of Ireland (the &#147;Issuer&#148;), provided notice that the Issuer has exercised its option to mandatorily exchange all $118.734 million in aggregate principal
amount of its 3.50% May 2014 Exchangeable Senior Notes due 2032 (the &#147;2014 Notes&#148;) into American Depositary Shares (&#147;ADSs&#148;) of Amarin, with each ADS representing one ordinary share of Amarin. As a result, Amarin will issue
384.6154 ADSs per $1,000 principal amount of 2014 Notes, subject to certain adjustments as provided in the Indenture, dated May 20, 2014 by and among the Issuer, Amarin, and Wilmington Trust, National Association, as trustee (the
&#147;Indenture&#148;) governing the 2014 Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amarin also announced today that it provided notice of the exercise of Amarin&#146;s option to
mandatorily exchange all $31.266 million in aggregate principal amount of its 3.50% November 2015 Exchangeable Senior Notes due 2032 (the &#147;2015 Notes&#148;) into ADSs of Amarin, with each ADS representing one ordinary share of Amarin. As a
result, Amarin will issue 384.6154 ADSs per $1,000 principal amount of 2015 Notes, subject to certain adjustments as provided in the 2015 Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
mandatory exchange of the 2014 Notes will be effective on September 12, 2016. As a condition to the mandatory exchange under the Indenture, the daily volume weighted average pricing per ADS equaled or exceeded $2.86 for at least 20 trading days in
the 30-trading-day period commencing on July 18, 2016 and ending on (and including) August 26, 2016. The date of notice of the exercise of Issuer&#146;s mandatory exchange option under the Indenture is August 26, 2016, and the &#147;Optional
Exchange Trigger Period&#148; under the Indenture began on July 18, 2016 and ended on (and included) August 26, 2016. The aggregate principal amount of 2014 Notes subject to the Issuer&#146;s mandatory exchange option is $118,734,000. The CUSIP
number of the 2014 Notes is 220480AB3. On and after the effective date of the exchange, interest on the 2014 Notes will cease to accrue. The name and address of the Paying Agent and Exchange Agent under the Indenture are as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Paying Agent: Wilmington Trust, National Association, 50 S. Sixth Street, Suite 1290, Minneapolis, MN55402, Attention: Corsicanto Ltd. Account Manager, Facsimile: 612- 617-5651 </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Exchange Agent: Wilmington Trust, National Association, 50 S. Sixth Street, Suite 1290, Minneapolis, MN55402, Attention: Corsicanto Ltd. Account Manager, Facsimile: 612- 617-5651 </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The mandatory exchange of the 2015 Notes will be effective on September 12, 2016. As a condition to the mandatory exchange under the 2015 Notes, the daily
volume weighted average </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
pricing per ADS equaled or exceeded $2.86 for at least 20 trading days in the 30-trading-day period commencing on July 18, 2016 and ending on (and including) August 26, 2016. The date of notice
of the exercise of Amarin&#146;s mandatory exchange option under the 2015 Notes is August 26, 2016, and the &#147;Optional Exchange Trigger Period&#148; under the 2015 Notes began on July 18, 2016 and ended on (and included) August 26, 2016. The
aggregate principal amount of 2015 Notes subject to the Issuer&#146;s mandatory exchange option is $31,266,000. On and after the effective date of the exchange, interest on the 2015 Notes will cease to accrue. The name and address of the Paying
Agent and Exchange Agent under the 2015 Notes are as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Paying Agent: Amarin Corporation plc, c/o Amarin Pharma Inc., 1430 US-206, Bedminster Township, NJ 07921, Attention: Chief Financial Officer </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Exchange Agent: Amarin Corporation plc, c/o Amarin Pharma Inc., 1430 US-206, Bedminster Township, NJ 07921, Attention: Chief Financial Officer </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This announcement is neither an offer to sell nor a solicitation of an offer to buy any of these securities and shall not constitute an offer, solicitation or
sale in any jurisdiction in which such offer, solicitation or sale is unlawful. The ADSs issuable upon exchange of the 2014 Notes and 2015 Notes will not be registered under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), or
the securities laws of any other jurisdiction, and may not be offered or sold in the United States absent registration under the Securities Act or an applicable exemption from registration requirements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About&nbsp;Amarin </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amarin Corporation plc is a
biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health.&nbsp;Vascepa<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (icosapent ethyl) capsules, Amarin&#146;s first
FDA-approved product, are a highly-pure, omega-3 fatty acid product available by prescription. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains forward-looking statements concerning Amarin&#146;s expectations, anticipations, intentions, beliefs or strategies regarding the
proposed exchange transaction, including the effective date thereof and the applicable conversion price of the 2014 Notes and 2015 Notes. These forward-looking statements are not promises or guarantees and involve substantial risks and
uncertainties. Among the factors that could cause actual results to differ materially from those described or projected herein are the following: the trading pricing of Amarin&#146;s ADSs between now and the effectiveness of the mandatory exchange,
financial market conditions, actions by our exchange counterparties prior to the closing of the exchange, our ability to continue to commercialize and increase market acceptance of Vascepa, our continued interactions with the FDA, the inherent
uncertainties maintaining intellectual property rights and protections, our ability to successfully operate under current and future collaboration arrangements, and the results of our current and future clinical trials. A further list and
description of these risks, uncertainties and other risks associated with an investment in Amarin can be found in Amarin&#146;s filings with the U.S. Securities and Exchange Commission, including its most recent Quarterly Report on Form 10-Q.
Existing and prospective investors are cautioned </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Amarin undertakes no obligation to update or revise the information contained in this
press release, whether as a result of new information, future events or circumstances or otherwise, except as required by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amarin contact
information: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Investor Relations: </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kathryn
McNeil</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investor Relations and Corporate Communications </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amarin Corporation plc </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In&nbsp;U.S.: +1 (908) 719-1315 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">investor.relations@amarincorp.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lee M. Stern </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Trout Group</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In&nbsp;U.S.: +1 (646) 378-2992 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">lstern@troutgroup.com<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Media Inquiries:</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kristie Kuhl </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Finn Partners </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In&nbsp;U.S.: +1 (212) 583-2791 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kristie.kuhl@finnpartners.com
</P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g100031g0826093420644.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g100031g0826093420644.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ] 38# 2(  A$! Q$!_\0
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ME;AZ&5S_ %H;BW<#YCKZ/^%>IV3> ;&$W,2R0EU=6< @[B>GXU<_X59X-_Z
MZ?\ ?QO\:!\+O!Z_=TE1])7']:J4E)6$C)^+>O:=%X-GL!=127-RRA(T<$\'
M))QVJY\+-3L9/ UC MW#YT65="X!4Y]*M'X6^#R<G2%)]Y&_QI4^%_A"-@R:
M4%(.<B5Q_6IO'EL,Z_J,BBFQQK%$D:#"H H'L*?68SR[XD?#2/68Y=8T>-4U
M!1NEA48$P]?][^=>5^ 8V3XAZ/'(A5EN<,K#D$ U]2URUUX!T:X\66WB-!+!
;>PMO98B DAQC+#'7Z8K2,[*S$=0**6BH __9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
